SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Lal PathLabs informs about allotment under ESOP

18 Dec 2024 Evaluate
Dr. Lal PathLabs has informed that the Board of Directors through Circular Resolution approved allotment of 5,483 Equity Shares under the ESOP 2010 Plan of the Company, on December 18, 2024. Pursuant to the above allotment, the Paid-up Equity Share Capital of the Company increased to INR 83,58,77,350 divided into 8,35,87,735 Equity Shares of INR 10 each.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

1403.15 -8.60 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×